Subbamma Jasti (#3050)
- $ 1 B
- Pharmaceuticals
- India
- F
- 92 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Subbamma Jasti inherited the assets of her husband Subba Rao Jasti, who died in 2023. The biggest chunk of her inheritance is derived from the sale of a substantial stake in listed Suven Pharmaceuticals in 2022 to global private equity firm Advent International. Jasti's son Venkateswarlu Jasti cofounded Suven Pharmaceuticals in 1989. The Hyderabad company was demerged in 2020 when Suven Life Sciences, which focuses on neuroscience therapies, was spun off and listed separately.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Subbamma Jasti’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Subbamma Jasti’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.2B
(May 4, 2026)
© Iconic Billionaires